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Introduction
The actin cytoskeleton is essential for numerous cellular and 
developmental processes involving membrane dynamics. These 
include endocytosis, cell migration, cytokinesis, and various 
morphogenetic processes. The polymerization, depolymeri-
zation, and 3D organization of actin filaments in cells are 
  governed by vast number of actin-binding proteins. Most 
actin-binding proteins are composed of multiple domains, per-
forming also regulatory and signaling functions. Among the 
plethora of actin-binding proteins are the actin fi  lament nu-
cleating Arp2/3 complex and its activators Wiskott-Aldrich 
  syndrome protein (WASP) and WASP family verprolin homo-
logous proteins (WAVEs), which promote formation of membrane 
protrusions downstream of the Rho-family GTPases (Pollard 
and Borisy, 2003). Although most actin-dependent processes 
involve reshaping of cellular membranes, the direct effects of 
  actin-binding proteins on the organization of membranes has 
not been reported.
One central group of proteins functioning at the interface 
between signaling and the actin cytoskeleton are insulin receptor 
substrate (IRS) p53, missing-in-metastasis (MIM), and their 
  homologues. These proteins share similar domain organization 
to each other, possessing a recently identifi  ed IRSp53/MIM 
  domain (IMD) at their N terminus. In addition to the IMD, MIM 
and some IRSp53 isoforms possess a C-terminal WH2 domain 
that binds actin monomers with high affi  nity (Mattila et al., 
2003; Woodings et al., 2003). Although the exact functions of 
IRSp53 and MIM are not defi  ned, both proteins are linked to the 
Arp2/3-mediated actin fi  lament assembly and formation of 
plasma membrane protrusions. IRSp53 interacts with the small 
GTPases Cdc42 and Rac through its N-terminal region and with 
WAVE2 through its central SH3 domain (Krugmann et al., 
2001). IRSp53 regulates the Arp2/3-modulating activity of the 
WAVE2 complex and is involved in lamellipodia and fi  lopodia 
formation in motile cells (Nakagawa et al., 2003; Suetsugu 
et al., 2006a). MIM was originally identifi  ed as a putative tumor 
suppressor because it is expressed in nonmetastatic, but absent 
from metastatic, bladder cancer cells (Lee et al., 2002; Loberg 
et al., 2005). MIM is a sonic hedgehog (Shh) responsive gene 
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and is strongly expressed during development in muscles and 
postmitotic neurons and in adult mice in kidneys, liver, and 
  Purkinje cells of the cerebellum (Mattila et al., 2003; Callahan 
et al., 2004). MIM enhances Arp2/3-mediated actin polymeriza-
tion through interactions with cortactin but inhibits WASP-
  mediated actin polymerization (Lin et al., 2005).
In cells, MIM and IRSp53 localize to the plasma mem-
brane and are involved in the formation of membrane protru-
sions. The fi  lopodia/membrane ruffl  e–inducing activity of MIM 
and IRSp53 resides in the N-terminal IMD, as indicated by a 
drastic induction of fi  lopodia when this domain is ectopically 
expressed in mammalian cells (Yamagishi et al., 2004;  Bompard 
et al., 2005). Previous studies demonstrated that recombinant 
IMDs bind and bundle actin filaments and interact with 
the small GTPase Rac, providing a plausible explanation for 
their filopodia-forming activity (Miki et al., 2000; Bompard 
et al., 2005).
The crystal structures of the IMDs from IRSp53 and MIM 
revealed an α-helical coiled-coil domain that self-associates 
into a “zeppelin-shaped” dimer (Millard et al., 2005; Lee et al., 
2007). Surprisingly, the closest structural homologues of IMD 
are the lipid-binding BAR (Bin/amphiphysin/Rvs) domains. BAR 
domain proteins (e.g., amphipysin, endophilin, and Rvs161/167) 
and related F-BAR domain proteins (e.g., toca and syndapin) 
induce tubular invaginations from the plasma membrane 
during the formation of an endocytic vesicle (Itoh and De 
  Camilli, 2006). In vitro, BAR domains evaginate liposomes into 
narrow tubules. They interact with negatively charged lipids 
through patches of positively charged residues at the concave 
face. Membrane deformation is driven by the intrinsic curvature 
of the rigid “banana-shaped” BAR domain dimer (Zhang and 
Hinshaw, 2001; Peter et al., 2004). In addition, an amphipathic 
N-terminal helix found in a subset of BAR domains (N-BARs) 
penetrates the membrane and potentiates the membrane-tubulating 
activity (Gallop et al., 2006; Masuda et al., 2006). In contrast to 
BAR domains, IMDs are involved in the formation of membrane 
protrusions, rather than membrane invaginations, and have not 
been reported to deform membranes.
Here, we provide evidence that IMDs deform PI(4,5)P2-
rich membranes into tubular structures. Unlike previously char-
acterized membrane-tubulating domains, the IMD appears to 
bind to the inner surface of the membrane tubule and therefore 
promote the formation of plasma membrane protrusions rather 
than invaginations. Identification of the PI(4,5)P2-binding 
  interface of the IMD provided a molecular explanation for 
this membrane-tubulating activity and revealed how this novel 
  function is linked to fi  lopodia formation in cells. We also show 
that the fi  lopodia-forming activity of MIM is independent of 
F-actin bundling and GTPase binding of the IMD.
Results
IMDs bind and deform 
PI(4,5)P2-rich membranes
IMDs share remote structural homology with BAR domains, 
which bind and deform lipid membranes in vivo and in vitro 
(Itoh and De Camilli, 2006). Despite the structural similarity, 
IMDs were proposed to promote fi  lopodia formation through 
their F-actin–bundling activity and thus form a functionally dis-
tinct group within the BAR domain family (Yamagishi et al., 
2004; Gonzalez-Quevedo et al., 2005; Millard et al., 2005). To 
examine whether IMDs display a BAR domain–like membrane-
binding activity, we studied the interaction of the IMD of MIM 
with various lipids by native gel electrophoresis. We found that 
it interacts with micelles containing PI(3,4)P2 and PI(4,5)P2 
(Fig. 1 A). The polar head group of PI(4,5)P2, IP3, or other phos-
pholipids did not shift the motility of MIM/IMD, suggesting the 
lack of a high-affi  nity interaction. The MIM/IMD–PI(4,5)P2 
 interaction was examined further in a more physiological context 
with a high-speed cosedimentation assay using synthetic lipid 
vesicles. The IMD of MIM cosedimented with vesicles con-
taining 30% PI(4,5)P2, whereas only weak cosedimentation was 
detected with vesicles without PI(4,5)P2 (Fig. 1 B). A more detailed 
analysis revealed that already 5–10% of PI(4,5)P2 considerably 
increased the affi  nity of MIM/IMD to vesicles (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200609176/DC1). 
This PI(4,5)P2 density is similar to the one reported for other 
PIP2-interacting proteins, such as N-WASP, which requires 
10–15% PIP2 density for activation (Papayannopoulos et al., 
2005). It is also important to note that, based on native gel 
  electrophoresis (Fig. 1 A) and cosedimentation assays (Fig. S1), 
the IMD of MIM binds PI(3,4,5)P3 with considerably lower 
 affi  nity than PI(4,5)P2.
Sequence database searches revealed two alternative 
splice variants of mouse MIM’s IMD. These differ from each 
other by a four-amino-acid insertion encoded by exon 7 (Fig. 
S2, A and B, available at http://www.jcb.org/cgi/content/full/
jcb.200609176/DC1). These residues are located at distal ends 
of the dimeric IMD (Fig. S2 C). The two alternatively spliced 
forms of the IMD of MIM are referred as MIM/IMD-L (longer 
splice variant) and MIM/IMD-S (variant lacking the four resi-
dues coded by exon 7). Importantly, both MIM/IMD-L and -S, 
as well as the IMD of IRSp53, interacted strongly with PI(4,5)P2-
containing vesicles, suggesting that PI(4,5)P2 binding is a func-
tion common among all IMDs (Fig. 1 B and Fig. S3).
To investigate the possible effects of IMDs on the struc-
ture of PI(4,5)P2-rich membranes, we performed an EM analy-
sis of MIM/IMD-L–PI(4,5)P2 vesicle complexes. Surprisingly, 
these experiments revealed a strong membrane deforming/ 
tubulating activity. Synthetic vesicles without MIM/IMD-L 
were heterogeneous in size, mostly spherical or curved in shape, 
and evenly distributed throughout the sample. In the presence of 
MIM/IMD-L, these vesicles formed clusters with complex 
  tubular structures (Fig. 1, C and D). Similar structures were also 
predominant in samples containing the IMD of IRSp53 (un-
published data). The structural organization of the IMD-induced 
membrane tubules was examined in more detail by using elec-
tron tomography. Because of the complex nature of structures 
induced by 22 μM MIM/IMD-L (Fig. 1 D), 1.1 μM protein was 
used in this experiment. The tomography analysis of a sel-
ected section is displayed in Fig. 1 E and Video 1 (available 
at http://www.jcb.org/cgi/content/full/jcb.200609176/DC1). 
MIM/IMD-L–induced tubules were of regular width (measured 
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was 60 nm and the widest 93 nm) independent of the protein 
concentration   (unpublished data). Amount of tubulation corre-
sponded with the amount of protein, and similar tubulation was 
observed in assays performed either with unilamellar or multi-
lamellar vesicles (Fig. 1 D). In contrast to the long tubular exten-
sions induced by BAR/F-BAR domains, electron tomography 
revealed that in   intact vesicular structures MIM/IMD-induced 
tubules are typically invaginating toward the interior of the ves-
icle (Fig. 1 E and Video 1). This observation suggests that IMDs 
tubulate membranes in a direction opposite that of BAR/F-BAR 
domains. It is also important to note that the amount of mem-
brane tubu  lation induced by MIM/IMD correlated with the 
PI(4,5)P2 density of the vesicles. High amounts of membrane 
tubules were   observed in experiments performed with 10–30% 
PI(4,5)P2 density. MIM/IMD also induced membrane tubula-
tion at 3–5% PI(4,5)P2, but this was less effi  cient than higher 
PI(4,5)P2 density (Fig. S1 C). Only very weak tubulation was 
detected with vesicles without PI(4,5)P2 (unpublished data). We 
also performed a similar assay by using two other PI(4,5)P2-
binding proteins, α-actinin and heterodimeric capping pro-
tein. These proteins did not induce membrane tubulation under 
similar conditions, confi  rming that this activity is not a gen-
eral feature of PI(4,5)P2-bnding proteins (unpublished data).
Mapping of the actin and PI(4,5)P2-binding 
sites of the IMD
To reveal the mechanisms of actin and phospholipid inter-
actions of the IMD, the PI(4,5)P2- and actin-binding sites of MIM/ 
IMD-L were mapped by systematic mutagenesis. 19 clusters of 
  mutations were individually created on the surface of MIM/
IMD-L using the 3D structure of the domain (Lee et al., 2007) 
as a guide. Each cluster of mutations contained one to three 
charged amino acids or surface-exposed hydrophobic residues 
substituted with alanines. The mutant clusters are evenly distrib-
uted over the surface of the IMD (Fig. 2, B and C; and Fig. S3 A).
The PI(4,5)P2 binding was examined by high-speed co-
sedimentation assay with synthetic lipid vesicles containing 30% 
PI(4,5)P2. Eight mutants displayed a substantially reduced affi  n-
ity for PI(4,5)P2 (Fig. 2 A and Fig. S3 B). Five of these (Mut10, 
-11, -12, -15, and -16) were clusters of charged residues that 
map close to the distal ends of the dimeric IMD, and two (Mut14 
and -17) contained substitutions of surface-exposed hydro-
phobic residues. These data show that the PI(4,5)P2-binding site 
of IMD consists of relatively large positively charged regions 
that are located at each end of the dimeric domain. This is fur-
ther supported by the observation that neutralizing the negative 
charge within this region (Mut13 [D143A]) increased the affi  nity 
Figure 1.  IMDs bind and tubulate PI(4,5)P2-
rich membranes. (A) Native gel electrophore-
sis analysis was performed with MIM/IMD-L 
alone (without lipids) or with MIM/IMD-L mixed 
with ﬁ   vefold molar excess of different phos-
pholipids. PI(3,4)P2 and PI(4,5)P2 caused 
MIM/IMD-L to move faster toward the anode, 
indicating an increase in negative charge and 
a binding interaction. IP3, inositol(1,4,5) trisphos-
phate headgroup; PI, phosphatidylinositol; 
PA, phosphatidic acid; MIX, lipid mixture 
(cholesterol, lecithin, and lysolecithin); and 
CAR, cardiolipin. MIM/IMD-L without lipids 
was loaded to the ﬁ   rst and last wells of the 
gels, respectively. (B) MIM/IMD-L and IRSp53/
IMD cosedimented with PI(4,5)P2-rich (30%) 
large multilamellar vesicles. More than 50% of 
MIM/IMD-L was found in the pellet fraction (P) 
in samples containing PI(4,5)P2, whereas much 
weaker association is seen with vesicles with-
out PI(4,5)P2. (C) EM analysis of multilamellar 
vesicles containing 30% of PI(4,5)P2 with and 
without MIM/IMD-L. Thin sections (60 nm) 
were visualized with transmission electron 
  microscope. Images were taken with magniﬁ  -
cations of 9,900 and 60,000. MIM/IMD-L 
clustered vesicles and deformed them into 
  tubular network structures. Bars: (top) 1 μm; 
(bottom) 0.2 μm. (D) EM micrographs of 120-nm-
thick sections of MIM/IMD-L deformed multi-
lamellar (top) and unilamellar (bottom) vesicles 
containing 30% PI(4,5)P2. Bars, 0.2 μm. 
(E) 3D electron tomography analysis of MIM/
IMD-L induced tubular network. (left) EM 
  micrograph of a 250-nm-thick section; (right) 
corresponding model where tubules that were 
not connected with the surface of the mem-
brane within the reconstructed volume were 
  removed. Membrane tubules (diameter of 78 nm) 
penetrate the vesicular structure. Bar, 0.1 μm.JCB • VOLUME 176 • NUMBER 7 • 2007  956
of IMD for PI(4,5)P2. In addition, surface-exposed leucines 
  located in these regions contribute to PI(4,5)P2 binding.
Actin fi  lament cosedimentation assay performed with 
1 μM IMD and 0–10 μM F-actin revealed that only four clusters 
of mutations (Mut11, -12, -15, and -16) displayed considerably 
lower affi   nity for F-actin as compared with wild-type IMD. 
  Combining these mutations further reduced F-actin binding, 
demonstrating the importance of these residues for actin interac-
tions (Fig. 2 A and Fig. S3 C). These residues map close to the ends 
of the dimeric IMD and overlap with the PI(4,5)P2-binding site, 
revealing that the positively charged region located in helix-2 forms 
the main actin- and PI(4,5)P2-binding site of the IMD (Fig. 2 C). 
As with the observed increase in PI(4,5)P2 binding, neutraliza-
tion of the negative charge within this region (Mut13 [D143A]) 
also increased the affi  nity of IMD to F-actin. However, in con-
trast to PI(4,5)P2 binding, none of the mutants (or double mu-
tants) resulted in a complete lack of F-actin binding, showing that 
IMDs interact with F-actin mostly through nonspecifi  c electro-
static interactions. To confi  rm the integrity of the mutants, we 
performed a urea denaturation assay for each double mutant used 
in the study. The mutants unfolded at the same urea concentra-
tion (4.5 M) as wild-type MIM/IMD, indicating that the muta-
tions did not affect folding of the protein (unpublished data).
PI(4,5)P2 binding of MIM/IMD is required 
for ﬁ  lopodia formation
Expression of IMDs in cultured mammalian cells induces a dra-
matic formation of fi  lopodia (Yamagishi et al., 2004; Gonzalez-
Quevedo et al., 2005; Millard et al., 2005). However, the 
dynamics of these structures (i.e., whether they are true mem-
brane protrusions or the result of cell retraction) have not been 
reported. Live-cell analysis of U2OS cells expressing MIM/IMD-L 
revealed that IMD-induced fi  lopodia are highly dynamic and 
extend with a rate of up to 1 μm/min (Fig. 3 A and Video 2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200609176/DC1). 
These protrusions are dependent on an intact actin cytoskeleton 
because treatment of the cells with latrunculin A decreased the 
dynamics of IMD-induced fi  lopodia (Video 3). Quantifi  cation 
of the data revealed that  40% of the fi  lopodia in untreated 
cells displayed elongation during the 60-s detection period, 
whereas after 6, 12, or 18 min of latrunculin A treatment, <5% 
of the fi  lopodia displayed elongation.
To examine the in vivo roles of PI(4,5)P2 interactions of 
IMD, we assayed fi  lopodia formation in U2OS cells expressing 
mutant IMDs. One of these (Mut12+15) displays severe de-
fects in F-actin binding and a nearly complete lack of PI(4,5)P2 
binding (Fig. 2) and loss of lipid vesicle tubulation activity (un-
published data). The other mutant (Mut14+17) interacts with 
F-actin with a similar affi  nity to wild-type IMD but shows a 
moderate defect in PI(4,5)P2 binding (Fig. 2 A and Fig. S3, 
B and C). The mutant defective in actin and PI(4,5)P2 binding 
failed to induce detectable fi  lopodia in U2OS cells. Interest-
ingly, Mut14+17, which displays defects only in PI(4,5)P2 
binding, induced signifi   cantly less fi   lopodia than wild-type 
IMD (Fig. 3 B). This demonstrates that interaction with PI(4,5)P2 
is critical for fi  lopodia formation by IMDs.
MIM/IMD localizes to the interface between 
F-actin bundles and plasma membrane
The experiments described above showed that IMDs bind and 
deform PI(4,5)P2-rich membranes in vitro and that the PI(4,5)P2 
Figure 2. Determination  of  PI(4,5)P2- and F-actin–binding sites of the IMD. 
(A) A list of mutants examined in this study. The PI(4,5)P2- and F-actin–binding 
properties of the mutants were determined by cosedimentation assays. 
The data obtained from F-actin–binding assays performed with four actin 
concentrations and from three independent PI(4,5)P2-binding assays are 
displayed (see Fig. S3, B and C, available at http://www.jcb.org/cgi/
content/full/jcb.200609176/DC1, for the data). Afﬁ  nities of mutant pro-
teins as compared with wild-type IMD are indicated. (B) The residues mu-
tated in this study are shown as ball and stick in the ribbon structure of 
MIM/IMD-L (Lee et al., 2007). Residues without detectable effects to 
PI(4,5)P2 binding are in green. Residues with moderate and strong defects 
in binding are in orange and in red, respectively. Substitution of Asp 143 
(blue) by Ala resulted in an increase in PI(4,5)P2 binding. (C) Presentation 
of the F-actin–binding site of MIM/IMD-L with the same color coding.MIM AND IRSP53 DEFORM MEMBRANES • MATTILA ET AL. 957
binding appears critical for the fi  lopodia-inducing  activity 
in vivo. 3D analysis, derived from seven confocal planes of fi  lo-
podia from cells expressing GFP-tagged MIM/IMD-L, revealed 
that the IMD does not localize to the F-actin bundle but instead 
localizes to the plasma membrane surrounding the F-actin bundle. 
The divergent localization was most obvious at the base of the 
fi  lopodium, where the GFP–MIM/IMD-L signal followed the 
plasma membrane rather than the F-actin bundle that extended 
into the cytoplasm (Fig. 4 A, right). In Fig. 4, MIM/IMD that 
does not colocalize with F-actin is shown in green. Because it 
surrounds the interior of fi  lopodia, the colocalization (yellow) 
and F-actin (red) signals are not visible in thin fi  lopodia when all 
channels are merged. A more detailed analysis revealed that 
F-actin and MIM/IMD colocalized only at a thin region within the 
fi  lopodia (Fig. 4 A, middle). The channel correlation in colocal-
ized volume, taking into account all the pixels in the 3D projec-
tion, was 0.6713 (calculated by Pearson’s correlation  coeffi  cient, 
where 1 represents perfect colocalization, 0 is no colocalization, 
and −1 is perfect inverse colocalization).   Together, these data 
demonstrate that MIM/IMD does not localize to the F-actin bundle 
but is instead found at the plasma membrane surrounding the 
bundle. Colocalization channel analysis further confi  rmed only 
a very thin interface where both proteins are present.
To investigate the possible cooperation between lipid- and 
actin-binding activities of IMDs, we examined samples con-
taining PI(4,5)P2-rich vesicles, F-actin, and IMD by light 
  microscopy. Alexa 568–labeled F-actin, MIM/IMD-L, and 
 fl  uorescein phosphatidylethanolamine (PE)–labeled vesicles 
with or without PI(4,5)P2 were mixed, applied on polyornithine-
coated glass slides, and imaged by light microscopy. In the pres-
ence of MIM/IMD-L and PI(4,5)P2, clear actin dots were found 
to localize at positions corresponding to vesicles (Fig. 4 B). 
  Importantly, vesicles without PI(4,5)P2 showed signifi  cantly 
weaker colocalization with actin, as was also found for PI(4,5)P2 
vesicles in an experiment using Mut15 (Fig. 4, B and C). 
The intensity of actin staining on vesicles was quantifi  ed, con-
fi  rming the importance of PI(4,5)P2 binding of IMD in the for-
mation of these denser F-actin dots (Fig. 4 C). Similar results 
were also obtained with the IMD of IRSp53 (unpublished data). 
The results demonstrate that IMDs are capable of associating 
actin fi  laments with PI(4,5)P2 vesicles, at least in vitro. How-
ever, it is important to note that the actin and PI(4,5)P2-binding 
sites overlap on the surface of the IMD (Fig. 2). This suggests 
that a fraction of IMDs associates in this assay with membranes 
only through one pole, leaving the other binding site access-
ible to actin. Alternatively, the membrane-bound IMD may 
  interact with actin through partially different interface than the 
soluble domain.
F-actin–bundling and Rac-binding 
activities of IMDs do not contribute 
to ﬁ  lopodia formation
IMDs were previously reported to induce fi  lopodia formation 
through their actin fi  lament–bundling activity (Yamagishi et al., 
2004; Gonzalez-Quevedo et al., 2005; Millard et al., 2005). 
However, our data showed that IMDs bind and deform mem-
branes and do not localize to actin bundles in fi  lopodia, as would 
be expected for an F-actin cross-linking protein. We thus per-
formed low-speed sedimentation assays to compare F-actin–
bundling activities of IMDs. Surprisingly, at physiological ionic 
Figure 3.  Compromised lipid binding weak-
ens the ability of an IMD to induce dynamic 
ﬁ  lopodia.  (A) Time-lapse images of a U2OS 
cell expressing GFP-tagged MIM/IMD-L. The 
black arrowhead shows the cell edge, and the 
white arrowhead indicates the tip of a growing 
ﬁ   lopodium. The ﬁ   lopodium extended with a 
rate of  1 μm/min. Bar, 1 μm. (B) Confocal 
images from U2OS cells overexpressing GFP-
tagged wild-type and mutant forms of MIM/
IMD-L. Mut12+15, which has severe defects 
in both F-actin and PI(4,5)P2 binding in vitro 
did not induce ﬁ   lopodia formation in cells. 
Mut14+17, which displayed moderate defects 
in PI(4,5)P2 binding but bound F-actin with 
wild-type afﬁ  nity in vitro, showed reduced ﬁ  lo-
podia formation compared with wild-type 
MIM/IMD-L. F-actin is in red. Bar, 10 μm. 
Quantiﬁ  cation of the number of ﬁ  lopodia per 
cell is shown in the diagram. SEM values are 
indicated as error bars. Analysis (t test) of the 
number of ﬁ  lopodia shows results to be statisti-
cally signiﬁ  cant  (n = 20). ***, P < 0.001; 
*, P < 0.05.JCB • VOLUME 176 • NUMBER 7 • 2007  958
conditions, MIM/IMD-L, MIM/IMD-S, and IRSp53/IMD dis-
played almost undetectable F-actin–bundling activity (Fig. 5, A 
and C), even though these proteins bound F-actin with affi  nities 
similar to the one previously reported for IMDs (Fig. S3 C). 
Under identical conditions, 1.25 μM α-actinin effi  ciently bun-
dled F-actin, suggesting that at physiological salt concentration, 
IMDs display only very weak actin fi  lament–bundling activity 
(Fig. 5 A).
Because some previous F-actin bundling assays with 
IMDs were performed at low ionic strength (Millard et al., 
2005) and IMDs appear to have a tendency to aggregate at low 
salt (Fig. 5 D), we performed a low-speed F-actin sedimentation 
assay at various salt concentrations. These data showed that the 
F-actin–bundling activity of IMDs (i.e., the amount of actin in 
the pellet fraction) increased sharply at low ionic strength (Fig. 
5, B and C). We next used dynamic light scattering (DLS) to 
  reveal whether the increased F-actin–bundling activity at sub-
physiological salt concentrations resulted from aggregation of 
MIM/IMD-L. DLS measures the fl  uctuation of scattered light, 
giving the distribution of hydrodynamic radii, I(Rh). Thus, DLS 
not only provides the information about the size (hydrodynamic 
radius; Rh) but also about the polydispersity of the sample (Kainov 
et al., 2003). DLS performed at different KCl concentrations 
  revealed a peak corresponding to the apparent size of IMD 
  dimer and peaks of larger radius corresponding to protein 
aggregates. At 100 mM KCl, the amount of aggregates was small, 
keeping in mind that the intensity of the peaks is proportional to 
the square of molecular mass and thus strongly enhances the 
signal from large particles. At lower salt concentrations, the 
amount of particles with Rh of >50 nm increased dramatically, 
indicative of protein aggregation (Fig. 5 D). Similar results were 
also obtained from a high-speed sedimentation assay, which 
demonstrated that MIM/IMD-L precipitated at low salt (un-
published data). Together, these data suggest that the previously 
reported F-actin–bundling activity of IMDs resulted from protein 
aggregation at nonphysiological ionic conditions. IMDs display 
only very weak F-actin bundling at physiological conditions 
that is unlikely to contribute to filopodia formation in vivo. 
  Furthermore, our analysis revealed that MIM/IMD-L does not 
bind G-actin or affect the nucleotide exchange or kinetics of 
  actin polymerization (unpublished data).
We next compared the binding of MIM/IMD-L and -S to 
recombinant Rac by GST pull-down and surface plasmon reso-
nance (SPR) assays. Surprisingly, these assays revealed a clear 
difference between MIM/IMD splice variant binding to Rac. In 
the GST pull-down assay, MIM/IMD-S interacted with dominant-
active (V12) and -inactive (N17) Rac, as described previously 
(Bompard et al., 2005), whereas no detectable binding of 
MIM/IMD-L to Rac was seen in this assay (Fig. 6 A). In the 
SPR assay, a concentration-dependent interaction of MIM/IMD 
to Rac was studied. Consistent with the pull-down assays, the 
obtained equilibrium binding level values showed that Rac 
Figure 4.  MIM/IMD-L localizes to the plasma 
membrane in ﬁ  lopodia and associates actin to 
membranes in vitro. (A) GFP–MIM/IMD-L lo-
calized to the plasma membrane and coated 
the F-actin bundles in ﬁ  lopodia of U2OS cell. 
3D analysis derived from seven confocal 
planes shows F-actin in red (all panels), MIM/
IMD in green (right), and colocalization in yel-
low (middle and right). Colocalization area 
(built by ImarisColoc software) is only a thin 
layer between actin and MIM/IMD and is al-
most invisible when the three channels are 
merged (right), as the MIM/IMD signal at the 
plasma membrane covers the interior of ﬁ  lo-
podia. Bar, 1 μm. (B) In vitro light microscopy 
assay. 1 μM F-actin (50% Alexa 568–labeled), 
2.5 μM MIM/IMD-L, and 1.67 μM lipid vesi-
cles (0/30% PI[4,5]P2) were mixed and ap-
plied on polyornithine-coated glass slides for 
imaging. In the presence of MIM/IMD-L and 
PI(4,5)P2, actin concentrated at the sites of 
vesicles, indicating MIM/IMD-L–associating 
actin and vesicles (top). MIM/IMD-L with vesi-
cles without PI(4,5)P2 or MIM/IMD-L Mut15, 
which displays defects in actin and PI(4,5)P2 
binding, induced much weaker colocalization 
between actin and vesicles. Red arrowheads 
indicate vesicles that show clear colocaliza-
tion with actin, and green arrowheads indi-
cate vesicles without colocalizing actin. Bar, 
20 μm. (C) The intensity of the actin staining 
on the vesicles was quantiﬁ   ed from 19–20 
randomly selected vesicles. Error bars indi-
cate SEM values. A t test was used to analyze 
p-values and showed statistically signiﬁ  cant 
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  interacted with MIM/IMD-L with a binding level of only 
10–15% of that of MIM/IMD-S (Fig. 6 B). A high background 
was obtained from the His-GST control channel, which makes 
the observed affi  nity of the MIM/IMD-L variant diffi  cult to in-
terpret, further proposing a very weak Rac interaction for this 
variant. Furthermore, our pull-down and SPR assays demon-
strated also that neither variant of MIM/IMD bound other small 
GTPases, such as RhoA and/or Cdc42, with detectable affi  nity 
(unpublished data).
Although only MIM/IMD-S binds Rac with detectable 
affi  nity, overexpression of either MIM/IMD-S or -L induced 
fi  lopodia formation in cells (Fig. 6 C). Quantifi  cation of fi  lopo-
dia number from transfected cells revealed no apparent differ-
ences between cells expressing MIM/IMD-S and -L (Fig. 6 D). 
This provided evidence that, in contrast to PI(4,5)P2 binding 
(Fig. 3 B), Rac binding is not necessary for fi  lopodia formation 
by IMDs.
Discussion
IRSp53 and MIM are relatively large, multidomain proteins that 
regulate cytoskeletal dynamics during motile and morpho-
genetic processes. Expression of full-length proteins or their 
N-terminal IMDs, which bind Rho family GTPases and bundle 
actin fi  laments, results in dramatic fi  lopodia/microspike formation 
in cultured mammalian cells (Yamagishi et al., 2004; Bompard 
et al., 2005). In this study, we determined the mechanism by 
which IMDs induce membrane protrusions in cells. We show 
that (1) IMDs display only very weak F-actin–bundling activity 
at physiological ionic conditions that is unlikely to contribute to 
fi   lopodia formation. The previously reported actin-bundling 
  activity appears to result from protein aggregation at low salt 
conditions. (2) Interaction with small GTPase Rac is not re-
quired for IMD-induced fi  lopodia formation. (3) IMDs bind and 
deform PI(4,5)P2-rich lipid membranes in vitro and localize to 
the interface of plasma membrane and F-actin bundles in fi  lopodia. 
(4) IMDs interact with membranes through a similar inter-
face to the structurally related BAR domains. However, IMDs 
and BAR domains generate an opposite membrane curvature 
because of the different geometries of their membrane-binding 
interfaces. (5) Interaction with PI(4,5)P2-rich membranes is 
necessary for the fi  lopodia-inducing activity of IMDs. Together, 
these fi  ndings show that IMD is a new functional member of 
the membrane-deforming BAR domain family. However, in 
contrast to previously characterized membrane-deforming do-
mains, IMDs induce formation of membrane protrusions rather 
than invaginations.
Here, we show that, in contrast to previous studies 
  (Yamagishi et al., 2004; Gonzalez-Quevedo et al., 2005; Millard 
et al., 2005), the IMD does not function as an F-actin–bundling 
motif at physiological ionic conditions. Although the IMD does 
not bundle F-actin, it binds actin fi  laments with a moderate 
 affi  nity. Previous charge-reversal mutagenesis studies revealed 
that a cluster of four positively charged residues at the ends of 
IMD dimer plays a central role in F-actin binding and bundling 
(Bompard et al., 2005; Millard et al., 2005). Our systematic muta-
genesis analysis revealed that the F-actin–binding site of the IMD 
of MIM is considerably larger and covers an  4-nm-long posi-
tively charged region along helix-2. Importantly, none of the muta-
tions in this study resulted in a complete lack of F-actin binding. 
Figure 5.  IMDs display weak F-actin–bundling 
activity at physiological ionic strength. (A) Low-
speed F-actin sedimentation assay, where actin 
bundles sedimented into the pellet fraction (P), 
whereas unbundled F-actin stayed in the super-
natant (S). F-actin concentration was 2 μM, 
and MIM/IMD dimer concentrations were 0, 
1.25, 2.5, and 5 μM. Human α-actinin was 
used as a control in dimer   concentration of 
1.25  μM. Note that although α-actinin efﬁ  -
ciently cross-linked F-actin, neither MIM/IMD-L 
or -S induced detectable F-actin bundling in 
this assay. (B) Low-speed F-actin sedimentation 
assay repeated in buffers containing different 
concentrations (100, 75, 50, or 25 mM) of 
KCl. The actin-bundling activity of both MIM/
IMD-L and IRSp53/IMD increased at lower 
KCl concentrations. (C) Quantiﬁ  cation of F-actin–
bundling activities of IMDs from three inde-
pendent experiments at 100/50 mM KCl. Error 
bars indicate standard deviations. (D) DLS 
  proﬁ   les of MIM/IMD-L at 100, 75, 50, or 
25 mM KCl. The amount of aggregates >50 nm 
in hydrodynamic radius increased at lower 
KCl concentrations. The mean of Rh distribu-
tions of two independent measurements is pre-
sented in the graphs.JCB • VOLUME 176 • NUMBER 7 • 2007  960
Even mutants in which fi  ve lysines/arginines were replaced by 
alanines bound F-actin with detectable affi  nity. This suggests 
that IMDs do not display a specifi  c actin-binding site, but 
  instead interact with F-actin through unspecifi  c electrostatic 
  interactions. In contrast, neutralizing specifi  c residues at the 
  actin-binding sites of other proteins such as actin-depolymerizing 
factor/cofi  lin or capping protein results in dramatic defects in 
actin binding (Lappalainen et al., 1997; Wear et al., 2003). The 
affi  nity of IMDs to F-actin is relatively low compared with most 
other F-actin–binding proteins (Yamagishi et al., 2004; Millard 
et al., 2005), suggesting a nonspecifi  c interaction with actin. In 
fi  lopodia, the IMD of MIM did not localize to F-actin bundles, 
as would be expected for an actin-bundling protein. At physio-
logical ionic strength, this domain displayed an extremely weak 
actin-bundling activity compared with the well-characterized 
cross-linking protein, α-actinin (Fig. 5). Effi  cient bundling was, 
on the other hand, induced by subphysiological ionic condi-
tions, where IMDs also form aggregates. It is important to note 
that although the IMD dimer contains two F-actin–binding sites, 
usually indicative of cross-linking activity, it appears to bind 
F-actin with relatively low affi  nity. Therefore,  simultaneous 
  interaction of both sites with F-actin, required to induce fi  lament 
cross-linking, is likely to be a rare event. Alternatively, the actin 
fi  lament may interact with these sites in an orientation that steri-
cally prevents the binding of another fi  lament. Together, these 
data suggest that IMDs do not bundle F-actin in cells.
MIM binds and activates Rac through its IMD. The Rac-
binding site is located at the ends of the IMD dimer and over-
laps with the actin-binding site (Bompard et al., 2005). Here, 
we show that only the shorter splice variant of MIM’s IMD in-
teracted with Rac, whereas the longer splice variant containing 
a four-amino-acid insertion in the loop between helix-2 and -3 
did not bind Rac or other Rho-family GTPases with a detect-
able affi  nity. In the 3D structure, the insertion in MIM/IMD-L 
is located at the ends of IMD dimer, providing further support 
that this region plays a central role in Rac binding. Importantly, 
both MIM/IMD-L and -S, which displayed dramatic differ-
ences in Rac binding, induced similar fi  lopodia  formation 
when expressed in cells. These data, together with previous 
studies showing that fi  lopodia formation by IMDs was not per-
turbed by the coexpression of dominant-negative Cdc42 or 
Rac1 (Yamagishi et al., 2004), provided evidence that Rac 
binding is not a critical function of IMDs during the formation 
of membrane protrusions. However, the differences between 
the two MIM splice variants in Rac binding suggest another, 
more specifi  c role for this interaction in the context of the full-
length proteins.
Our biochemical and EM analyses revealed that IMDs 
bind phosphatidylinositides and deform membranes into tubu-
lar structures. The observed PI(4,5)P2 binding is in line with 
  recent data showing that the N-terminal region of IRSp53 
 (containing the IMD) binds phospholipids in vitro (Suetsugu 
et al., 2006a). IMDs did not bind IP3, the polar headgroup of 
PI(4,5)P2, with detectable affi  nity. This result also implicates 
that the fatty acid chains of PI(4,5)P2 are important for the inter-
action or that IMD interacts only with membranes where the 
Figure 6.  Interaction with small GTPase Rac 
is not required for IMD-induced ﬁ  lopodia for-
mation. (A) The binding of MIM/IMD variants 
to Rac was determined by a GST pull-down 
assay under physiological ionic conditions. 
GST fusion of recombinant Rac (V12) or GST 
alone were coupled to glutathione–Sepharose 
beads and incubated with MIM/IMD splice 
variants. The beads were sedimented, washed 
three times, and loaded on SDS gels. MIM/
IMD-S clearly bound Rac, whereas no binding 
of MIM/IMD-L was detected with this assay. 
(B) The binding of GST-Rac (V12) to MIM/
IMD variants examined with a Biacore 2000. 
The histograms represent the equilibrium bind-
ing levels (Req) in resonance units that were 
obtained for each Rac concentration with 
binding of MIM/IMD-L or -S. (C) U2OS cells 
overexpressing GFP-tagged MIM/IMD-S or -L. 
Both MIM/IMD variants induced ﬁ  lopodia-like 
protrusions in cells in a similar manner. F-actin 
visualized with Alexa 568 phalloidin. Bar, 10 μm. 
(D) Quantiﬁ   cation of ﬁ   lopodia number in 
GFP, GFP–MIM/IMD-L, and GFP–MIM/IMD-S 
transfected U2OS cells (n  = 10). Between 
MIM/IMD splice variants no difference was 
seen, suggesting that Rac binding is not re-
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inositol headgroups are aligned. The latter alternative is sup-
ported by our mutagenesis analysis, revealing that the PI(4,5)P2-
binding site is composed of relatively large positively charged 
surfaces at each end of the dimer. Although the peculiar sym-
metry of IMDs results in an  140° rotation of the dimer ends to 
each other, the two positively charged PI(4,5)P2-binding patches 
are facing the same direction when the domain is aligned with 
amphiphysin BAR domain (Fig. 7 A). This model shows that 
IMDs bind lipids through an interface similar to that found in 
BAR domains. It is also important to note that membrane, Rac, 
and actin binding seem to take place roughly through the same 
area of the molecule, suggesting that these interactions compete 
with each other. However, of these activities, only PI(4,5)P2 
binding is necessary for the fi  lopodia formation, suggesting that 
the other (competitive) interactions may have a regulatory role.
The membrane-tubulation activity of IMDs is also sup-
ported by a recent study, which demonstrated that the IMD of 
IRSp53 can deform PI(3,4,5)P3-rich membranes in vitro 
  (Suetsugu et al., 2006b). However, this activity was reported to 
be Rac dependent, whereas our data demonstrates that IMD-
  induced membrane tubulation is independent from Rac both 
in vitro and in vivo. Furthermore, in contrast to our study, the IMD 
of MIM was not capable in deforming membranes in the study 
by Suetsugu et al. (2006b). These differences may arise from 
the fact that these authors used PI(3,4,5)P3 in their EM studies, 
whereas PI(4,5)P2 was used in our study. Our results showed 
that MIM/IMD binds PI(4,5)P2 with substantially higher affi  n-
ity than PI(3,4,5)P3 both at native gel electrophoresis and co-
sedimentation assays. Because PI(4,5)P2 is also >25-fold more 
abundant at the plasma membrane than PI(3,4,5)P3 (Rameh and 
Cantley, 1999), PI(4,5)P2 is most likely the physiological bind-
ing partner of IMDs during membrane deformation/fi  lopodia 
formation in cells. It is also important to note that the mem-
brane-binding interface of an IMD determined in our work is 
much more extensive than the one identifi  ed by Suetsugu et al. 
(2006b). This may arise either from the different lipids used in 
these assays or from the more extensive mutagenesis approach 
that was applied in our study.
Importantly, several lines of evidence suggest that IMDs 
generate a membrane curvature opposite to that of BAR 
  domains. (1) Our electron tomography analysis revealed that 
the tubular structures induced by MIM/IMD-L often penetrate 
toward the interior of the vesicular structure. In contrast, BAR 
and F-BAR domains deform liposomes into morphologically 
different, separate narrow tubes (Takei et al., 1999; Itoh et al., 
2005; Tsujita et al., 2006). (2) The lipid-binding interfaces of 
BAR and IMDs display opposite curvatures (Fig. 7 A). Interest-
ingly, the curvature of the PI(4,5)P2-binding interface measured 
from a space-fi  lling model of the 18-nm-long IMD dimer sug-
gests that MIM/IMD would induce a formation of a membrane 
tubule with a diameter of  95 nm. This corresponds well with 
the diameter of MIM/IMD-L–induced membrane tubules mea-
sured from electron micrographs ( 80 nm). (3) When expressed 
in cells, IMDs induce fi  lopodia, as compared with plasma mem-
brane invaginations induced by BAR domains. Thus, in contrast 
to the previously characterized lipid-deforming domains (BAR, 
F-BAR, and ENTH/ANTH), IMDs appear to generate an opposite 
membrane curvature. A hypothetical model for how IMDs 
 induce  fi  lopodia formation through their membrane-tubulating 
activity is presented in Fig. 7 (B and C). In addition to mem-
brane deformation, IMDs may also cross-link F-actin to the 
plasma membrane. However, further studies are required to elu-
cidate the possible biological signifi  cance of this activity.
Actin dynamics are closely linked to membrane-deformation 
processes such as endocytosis (Kaksonen et al., 2006). Our data 
provide fi  rst evidence that, in addition to N-WASP–induced 
  endocytic processes (Innocenti et al., 2005), plasma membrane 
protrusions are generated through interplay between actin 
  polymerization machinery and direct membrane deformation. 
IRSp53 has been implicated in lamellipodia formation via 
WAVE/SCAR-2 complex and shown to activate WAVE2, an 
Arp2/3 activator (Miki et al., 2000; Choi et al., 2005; Suetsugu 
et al., 2006a). Localization of IRSp53 to the plasma membrane is 
dependent on its N-terminal IMD (Miki et al., 2000; Nakagawa 
et al., 2003; Choi et al., 2005; Suetsugu et al., 2006a). MIM 
  localizes to filopodia, lamellipodia, and cell–cell junctions 
Figure 7.  Schematic model for the mechanism of ﬁ  lopodia formation by 
IMDs. (A) Structures of amphiphysin BAR domain (left; Protein Data Bank 
ID: 1URU) and MIM/IMD (right; Protein Data Bank ID: 2D1L). The residues 
indicated in membrane binding in amphiphysin BAR (Itoh and De Camilli, 
2006) and MIM/IMD (this study) are indicated in red. Purple dashed line 
indicates the proposed membrane interface. (B) Schematic model of mem-
brane tubulation by BAR domain (left) and IMD (right). BAR domains 
form a coat outside of membrane tubule, whereas MIM/IMD curves the 
  membrane in reversed orientation by binding to the inside of the tubule. 
(C) A side view of a BAR domain–induced endocytic invagination and an 
IMD-induced ﬁ   lopodium. Note that in addition to membrane-tubulating 
  activities mediated by BAR and IMDs, both processes are also linked to 
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(unpublished data), suggesting a role in actin-dependent mor-
phogenetic processes at the plasma membrane. Similarly, sev-
eral BAR domain proteins also interact with the regulators of 
actin dynamics. For example, yeast Rvs167/161 complex is 
  intimately involved in actin assembly during endocytosis and 
mammalian tuba binds Arp2/3 activator N-WASP (Salazar 
et al., 2003; Kaksonen et al., 2005). Similarly, F-BAR proteins 
toca-1 and syndapin interact with N-WASP (Qualmann et al., 
1999; Ho et al., 2004).
In conclusion, our study places the IMD in a new func-
tional subbranch of the membrane-deforming BAR domain 
family. However, because of the unique geometry of its 
PI(4,5)P2-binding site, an IMD induces membrane protrusions 
rather than invaginations. In the future, it will be important to 
reveal the detailed mechanism by which IMDs interact with 
membranes. Because IMDs have a tendency to form multi-
mers at low salt conditions, it will be interesting to determine 
the possible role of the IMD oligomerization or cooperativity 
during membrane deformation. Elucidating the mechanism by 
which the interplay between different functions of IRSp53 
and MIM (membrane deformation, actin monomer binding, 
and WAVE2 interactions) contribute to cell migration and 
morphogenesis will also provide important challenges for 
 future  research.
Materials and methods
Protein expression and puriﬁ  cation
MIM/IMD-L was cloned into the SpeI–HindIII sites of pHAT1 vector 
(Peranen et al., 1996). The site-directed mutagenesis was performed as in 
Mattila et al. (2004). GFP fusions of MIM/IMDs were constructed into the 
XhoI–BamHI sites of pEGFP-N1 (CLONTECH Laboratories, Inc.). Alleles 
encoding mutant GTPases were cloned into BamHI–HindIII (Rac) or EcoRI–
HindIII (RhoA, Cdc42) sites of pGEX-2T (GE Healthcare; Vartiainen et al., 
2000). The human IRSp53 construct was provided by H. Nakagawa 
  (Kyushu Institute of Technology, Kyushu, Japan), and IRSp53/IMD cDNA was 
cloned into SpeI–NsiI sites of pHAT1. All IMD constructs were expressed 
as His tag fusion proteins, enriched with Ni-NTA Superﬂ  ow beads (Sigma-
Aldrich), and purified with Q-Sepharose high-performance anion-
exchange column (GE Healthcare). Small GTPases Rac, RhoA, and Cdc42 
were expressed as GST fusion proteins, enriched with glutathione-agarose 
beads (Sigma-Aldrich), and puriﬁ  ed by Superdex-75 HiLoad gel ﬁ  ltration 
column (GE Healthcare). Human skeletal muscle α-actinin 2 (provided by 
J. Ylänne, University of Jyväskylä, Finland) was expressed and puriﬁ  ed 
from pET8c-6HTEV plasmid (Young and Gautel, 2000). Rabbit muscle 
  actin was prepared from acetone powder as described by Pardee and 
Spudich (1982).
Preparation of lipid vesicles
PI(4,5)P2 ( L-a-phosphatidylinositol-4,5-bisphosphate; porcine brain tri-
ammonium salt), PI(3,4,5)P3 (1,2-dioctanoyl-sn-glycero-3-[phosphoinositol-
3,4,5-trisphosphate], tetra-ammonium salt), phosphatidylcholine (PC; 
brain), phosphatidylserine (PS; brain), and ﬂ  uorescein PE (18:1 PE/CF 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[carboxyﬂ  uorescein]) 
were purchased from Avanti Polar Lipids, Inc. PC and PS were dissolved 
in 9:1 chloroform/methanol, PI(4,5)P2 was dissolved in 1:2 chloroform/
methanol, PI(3,4,5)P3 was dissolved in 65:35:8 chloroform/methanol/
water, and ﬂ  uorescein PE was supplied in chloroform. The following mix-
tures were prepared: 5% ﬂ   uorescein PE, 20% PS, 45–75% PC, and 
0–30% PI(4,5)P2. Samples were vacuum dried under N2 and hydrated for 
a minimum of 4 h in 0.2 mM Hepes-KOH, pH 7.5, and 100 mM NaCl to 
a total lipid concentration of 1 mM. Finally, the vesicles were vortexed 
thoroughly for 2 min to allow formation of large multilamellar vesicles. 
Vortexing was repeated before each experiment. When preparing uni-
lamellar vesicles, hydrated lipids were subjected to extrusion through a 
1-μm ﬁ  lter according to manufacturer’s instructions (Mini-Extruder; Avanti 
Polar Lipids, Inc.).
EM
Vesicles (167 μM total lipid and 3, 5, or 30% PI[4,5]P2) were mixed with 
0, 1.1 (for tomography), or 22 μM IMD dimer in F-buffer (5 mM Tris-HCl, 
pH 7.5, 0.2 mM ATP, 0.2 mM DTT, 0.2 mM CaCl2, 2 mM MgCl2, and 100 
mM KCl). Reactions were incubated for 30 min and ﬁ  xed by adding 2.1% 
glutaraldehyde and 0.1 M Hepes for 30 min at RT. Samples were sedi-
mented (17,000 g at 4°C) and postﬁ   xed by osmication (1% OsO4, 
15 mg/ml K4[Fe{CN}6], and 0.1 M Na-cacodylate buffer, pH 7.4), for 1 h, 
followed by en bloc staining with uranyl acetate (1% uranyl acetate and 
0.3 M sucrose) for 1 h at 4°C, dehydration, and Epon embedding. Thin 
(60 nm) or semi-thick (120 nm) sections were prepared and stained with 
uranyl acetate and lead citrate for visualization with a transmission elec-
tron microscope (FEI Tecnai 12; FEI Corp.) operated at 120 kV. Images 
were recorded using a charge-coupled device camera (Erlangshen 
ES500W; Gatan Corp.).
Electron tomography
For 3D electron tomography, a 250-nm-thick section was prepared as de-
scribed above and imaged with an electron microscope (Tecnai 20 FEG; FEI 
Corp.) operating at 200 kV. Images were recorded with a 1k × 1k change-
coupled device camera (Multiscan 794; Gatan Corp.) at a magniﬁ  cation of 
11,500× (1.63 nm/pixel). For collection of tilt series, the specimen was 
tilted  ±70° at 1° intervals around two orthogonal axes (Mastronarde, 
1997). The alignment and reconstruction of tilt series was done with the 
IMOD program package (Kremer et al., 1996) using 10-nm colloidal gold 
particles as ﬁ  ducial markers. The tomographic reconstruction was visualized 
and modeled with Amira software using volume rendering (TGS, Inc.).
Cosedimentation assays
Actin ﬁ  lament cosedimentation assays were performed as described previ-
ously (Mattila et al., 2003; Woodings et al., 2003). For lipid-binding as-
says, 20 μl of buffer (20 mM Hepes-KOH, pH 7.5, and 100 mM NaCl) or 
buffer with vesicles of 167 μM total lipid concentration was added to 
25 μl of F-buffer. IMD constructs (5 μl) were diluted in desired concentrations 
in F-buffer. In high-speed (F-actin or vesicle binding) assays, samples were 
sedimented by centrifugation at 360,000 g for 30 min at RT. In low-speed 
F-actin bundling assays, samples were sedimented at 17,000 g for 30 min 
at 4°C. 12% SDS-polyacrylamide gels were scanned with a calibrated 
  imaging densitometer (GS-710; Bio-Rad Laboratories, Inc.) and quantiﬁ  ed 
with Quantity One software.
Cell culture and light microscopic methods
Immunoﬂ  uorescence and transfection of human osteosarcoma (U2OS) cells 
with GFP-MIM/IMD constructs were performed as described by Hotulainen 
and Lappalainen (2006). F-actin was visualized with Alexa 568 phalloidin 
(dilution 1:400; Invitrogen). To block actin polymerization, cells were 
treated with 0.2 μg/ml latrunculin A (Invitrogen). For analysis of the asso-
ciation of actin and vesicles in vitro, samples containing 2.5 μM MIM/
IMD-L dimer, 1.67 μM lipid vesicles (0 or 30% PI[4,5]P2), and 1 μM 
F-actin (50% Alexa Fluor 568–labeled actin) were prepared for light micro-
scopy in modiﬁ  ed F-buffer (10 mM imidazole, pH 7.5, 0.2 mM CaCl2, 
0.2 mM ATP, 1 mM DTT, 100 mM KCl, 2 mM MgCl2, and 1 mM EGTA). 2-μl 
samples from reactions were applied on polyornithine-coated glass slides. 
Images were acquired through a charge-coupled device camera (DP70; 
Olympus) on a microscope (AX70 Provis; Olympus). For the image ac-
quirement, the AnalySIS software (Olympus) and PlanApo 60×/1.40 (oil) 
objective (Olympus) was used. For in vitro samples, images were acquired 
with ﬁ  xed exposure times for quantiﬁ  cation with TINA software. The confo-
cal image stacks were deconvoluted with AutoQuant AutoDeblur 3D Blind 
Deconvolution (AutoQuant Imaging, Inc.), and the 3D reconstructions and 
the colocalization analysis were made with Bitplane Imaris (Bitplane Inc.). 
The time-lapse images were acquired with an inverted microscope (IX70; 
Olympus) equipped with a Polychrome IV monochromator (TILL Photonics) 
with the appropriate ﬁ  lters, heated sample environment, CO2 control, and 
40×/1.35 (oil) objective. Total internal reﬂ  ectance ﬂ  uorescence (TIRF) was 
performed using 60×/1.45 (oil) TIRF objective and 488 nm laser.
DLS
Samples (0.5 mg/ml of IMD in F-buffer with desired KCl concentrations) 
were prepared, incubated for 1 h at 20°C, and monitored with a batch 
DLS instrument (Precision Detectors) equipped with deconvolution software 
for correlation function analysis (Kainov et al., 2003).
GST pull-down assay
GST pull-down assays were performed as in Mattila et al. (2004). Beads 
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2.5 μM MIM/IMD dimer in 10 mM Tris, pH 7.5, and 100 mM NaCl for 
10 min at RT, washed three times with 500 μl of reaction buffer, and 
  analyzed on 12% SDS-PAGE.
SPR measurement
Interaction of Rac with MIM/IMD was studied with SPR on nitrilotriacetic 
acid sensor chip on a Biacore 2000 (Biacore AB) with a ﬂ  ow rate of 
20 μl/min according to the manufacturer’s instructions. The assay was per-
formed in 10 mM Hepes-KOH, pH 7.2, and 150 mM NaCl with an injec-
tion contact time of 5 min and a dissociation time of 10 min. The 
recombinant His-tagged MIM/IMD splice variants and His-tagged GST 
proteins were immobilized by nickel chelation on nitrilotriacetic acid sen-
sor surface to saturating levels (in the range of 9,000 resonance units) to 
facilitate detection of putatively low-afﬁ  nity interactions. Binding of GST-
Rac to MIM/IMD splice variants was studied under the system conditions 
between 20 and 300 nM Rac concentrations. To obtain binding levels at 
steady state, the control sensorgram, coated with His-GST, was subtracted 
from each MIM/IMD sensorgram. The steady-state binding levels of sensor-
grams were evaluated by Langmuir 1:1 binding model modiﬁ  ed to mass 
transfer effect in Biacore Evaluation Software 3.1. The obtained equilib-
rium binding level responses are given as resonance units.
Miscellaneous
The coordinates for 3D structure of the MIM/IMD (Lee et al., 2007) were 
obtained from R. Dominguez (University of Pennsylvania, Philadelphia, 
PA). Protein concentrations were determined with a diode array spectro-
photometer (8452A; Hewlett Packard) by using the calculated extinction 
coefﬁ   cients for mouse MIM/IMD-L and -S (ε280  = 15,220 M
−1cm
−1), 
IRSp53/IMD (ε280 = 19,770 M
−1cm
−1), and actin (ε290-340 = 26,600 
M
−1cm
−1). The native PAGE analysis for detecting the lipid interaction of 
MIM/IMD was performed as previously described (Palmgren et al., 2001). 
Fluorescence-monitored urea denaturation assays were performed as 
  described by Lappalainen et al. (1997).
Online supplemental material
Fig. S1 shows that MIM/IMD prefers PI(4,5)P2 over PI(3,4,5)P3, the bind-
ing afﬁ  nity correlates with phosphoinositide density of vesicles, and MIM/
IMD is capable of tubulating membranes with low PI(4,5)P2 density. Fig. S2 
illustrates two alternative splice variants of MIM/IMD. Fig. S3 shows the 
PI(4,5)P2 and F-actin–binding experiments on MIM/IMD-L mutants. Video 1 
shows electron tomography of MIM/IMD-induced membrane tubules. In 
Video 2, the dynamics of MIM/IMD-induced ﬁ   lopodia are shown, and 
Video 3 demonstrates that the dynamics of MIM/IMD-induced ﬁ  lopodia is 
abolished by latrunculin A treatment. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200609176/DC1.
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